![Donna Grogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 349 564 $ al 30/06/2026
Donna Roy Grogan is currently Independent Director at C4 Therapeutics, Inc. since 2022 and President at Clementia Pharmaceuticals USA, Inc. since 2014.
Former roles include Independent Director at Momenta Pharmaceuticals, Inc. from 2019 to 2020; Medical Director at Astra Pharmaceuticals, Inc.; Senior Vice President-Clinical Research at Sumitomo Pharma America, Inc. from 2000 to 2007; Chief Medical Officer at DecImmune Therapeutics, Inc., Apofore Corp., Anexon, Inc.; Chief Medical Officer at Clementia Pharmaceuticals, Inc. from 2013 to 2019; and Chief Medical Officer at FoldRx Pharmaceuticals LLC from 2007 to 2010.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts) and a doctorate from the University of Illinois College of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
C4 THERAPEUTICS, INC. 0,07 % | 01/07/2026 | 74.853 ( 0,07 % ) | 349 564 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director/Miembro de la Junta | 29/07/2022 |
Clementia Pharmaceuticals USA, Inc.
 Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Presidente | 01/06/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/10/2020 |
| CLEMENTIA PHARMACEUTICALS INC | Director Técnico/Científico/I+D | 01/04/2019 |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Director Técnico/Científico/I+D | 01/08/2011 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01/01/2007 |
DecImmune Therapeutics, Inc.
 DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides drug discovery and clinical development services | Health Technology |
DecImmune Therapeutics, Inc.
DecImmune Therapeutics, Inc. BiotechnologyHealth Technology Develops novel peptides and antibodies for acute and tissue damaging inflammation | Health Technology |
Apofore Corp.
 Apofore Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for diabetes | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astra Pharmaceuticals, Inc. | |
Anexon, Inc.
 Anexon, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
University of Illinois College of Medicine
 University of Illinois College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Clementia Pharmaceuticals USA, Inc.
Clementia Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
